---
title: "Token Sciences released its performance for the first three quarters, with a net profit attributable to the parent company of 285 million yuan, a decrease of 2.54%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263074960.md"
description: "According to the Zhitong Finance APP, Token Sciences released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 8.958 billion yuan, a year-on-year increase of 3.72%. The net profit attributable to shareholders of the listed company was 285 million yuan, a year-on-year decrease of 2.54%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 265 million yuan, a year-on-year increase of 1.69%. The basic earnings per share were 0.1159 yuan"
datetime: "2025-10-28T11:51:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263074960.md)
  - [en](https://longbridge.com/en/news/263074960.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263074960.md)
generator: "portal-rs"
---

# Token Sciences released its performance for the first three quarters, with a net profit attributable to the parent company of 285 million yuan, a decrease of 2.54%

According to the Zhitong Finance APP, Token Sciences (300088.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 8.958 billion yuan, a year-on-year increase of 3.72%. The net profit attributable to shareholders of the listed company was 285 million yuan, a year-on-year decrease of 2.54%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 265 million yuan, a year-on-year increase of 1.69%. The basic earnings per share were 0.1159 yuan

### Related Stocks

- [300088.CN](https://longbridge.com/en/quote/300088.CN.md)

## Related News & Research

- [Zaptec insider-linked company buys shares worth NOK 12.36 million](https://longbridge.com/en/news/296378460.md)
- [VIMAB: Strong Q2 revenue growth and new battery contracts signal improving performance](https://longbridge.com/en/news/296577862.md)
- [Callosum raises USD 100 million seed round led by Atomico](https://longbridge.com/en/news/296446845.md)
- [DIMRI: H1 2026 net profit rose to ₪495.6M on revenue of ₪780.5M, with robust liquidity and equity](https://longbridge.com/en/news/296448412.md)
- [Rapala VMC: Strong H1 sales and profit growth led to upgraded full-year outlook amid ongoing trade risks](https://longbridge.com/en/news/296480810.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**